Akari Therapeutics Plc (AKTX)

CIK 1541157 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Akari Therapeutics Plc.

Recent SEC filings

FiledFormAccession number
Oct 30, 2026S-80001493152-26-049453
Oct 30, 20268-K0001493152-26-049446
Oct 16, 202640001493152-26-047456
Oct 16, 202640001493152-26-047458
Oct 16, 202640001493152-26-047453
Oct 16, 202640001493152-26-047454
Oct 16, 202640001493152-26-047455
Oct 16, 202640001493152-26-047457
Oct 14, 202640001493152-26-047058
Oct 14, 202630001493152-26-047057
Oct 1, 20268-K0001493152-26-045364
Oct 1, 2026DEF 14A0001493152-26-045371
Oct 1, 202640001493152-26-045366
Aug 19, 202640001493152-26-039246
Aug 13, 202610-Q0001493152-26-037730
Aug 13, 20268-K0001493152-26-037736
Aug 12, 2026SCHEDULE 13G0000927971-26-000091
Aug 7, 2026SCHEDULE 13G0001952614-26-000004
Aug 5, 202640001493152-26-036231
Jul 17, 202640001493152-26-033634
Jul 13, 2026EFFECT9999999995-26-002279
Jul 10, 2026S-3/A0001493152-26-032841
Jul 8, 2026S-3/A0001493152-26-032503
Jul 7, 2026EFFECT9999999995-26-002205
Jul 2, 20268-K0001493152-26-031972